Annual Shareholders Equity
$811.02 M
-$289.80 M-26.33%
December 31, 2023
Summary
- As of February 12, 2025, AGIO annual stockholders equity is $811.02 million, with the most recent change of -$289.80 million (-26.33%) on December 31, 2023.
- During the last 3 years, AGIO annual shareholders equity has risen by +$411.52 million (+103.01%).
- AGIO annual shareholders equity is now -37.23% below its all-time high of $1.29 billion, reached on December 31, 2021.
Performance
AGIO Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$1.63 B
+$966.16 M+146.28%
September 30, 2024
Summary
- As of February 12, 2025, AGIO quarterly stockholders equity is $1.63 billion, with the most recent change of +$966.16 million (+146.28%) on September 30, 2024.
- Over the past year, AGIO quarterly shareholders equity has increased by +$966.16 million (+146.28%).
- AGIO quarterly shareholders equity is now -29.17% below its all-time high of $2.30 billion, reached on March 31, 2021.
Performance
AGIO Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
AGIO Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -26.3% | +146.3% |
| 3 y3 years | +103.0% | +16.6% |
| 5 y5 years | +18.0% | +262.9% |
AGIO Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -37.2% | at low | at high | +146.3% |
| 5 y | 5-year | -37.2% | +103.0% | -29.2% | +307.2% |
| alltime | all time | -37.2% | +1747.5% | -29.2% | +5534.1% |
Agios Pharmaceuticals Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $1.63 B(+146.3%) |
| Jun 2024 | - | $660.51 M(-11.2%) |
| Mar 2024 | - | $743.92 M(-8.3%) |
| Dec 2023 | $811.02 M(-26.3%) | $811.02 M(-8.5%) |
| Sep 2023 | - | $886.84 M(-8.0%) |
| Jun 2023 | - | $964.24 M(-7.0%) |
| Mar 2023 | - | $1.04 B(-5.8%) |
| Dec 2022 | $1.10 B(-14.8%) | $1.10 B(+4.8%) |
| Sep 2022 | - | $1.05 B(-6.6%) |
| Jun 2022 | - | $1.12 B(-6.9%) |
| Mar 2022 | - | $1.21 B(-6.5%) |
| Dec 2021 | $1.29 B(+223.4%) | $1.29 B(-7.4%) |
| Sep 2021 | - | $1.39 B(-19.0%) |
| Jun 2021 | - | $1.72 B(-25.0%) |
| Mar 2021 | - | $2.30 B(+474.9%) |
| Dec 2020 | $399.50 M(-37.6%) | $399.50 M(-16.8%) |
| Sep 2020 | - | $480.45 M(-14.0%) |
| Jun 2020 | - | $558.47 M(-10.7%) |
| Mar 2020 | - | $625.30 M(-2.4%) |
| Dec 2019 | $640.53 M(-6.8%) | $640.53 M(+42.9%) |
| Sep 2019 | - | $448.29 M(-15.8%) |
| Jun 2019 | - | $532.68 M(-14.1%) |
| Mar 2019 | - | $620.26 M(-9.8%) |
| Dec 2018 | $687.54 M | $687.54 M(-9.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2018 | - | $760.21 M(-7.6%) |
| Jun 2018 | - | $823.14 M(-4.9%) |
| Mar 2018 | - | $865.59 M(+130.5%) |
| Dec 2017 | $375.50 M(+4.7%) | $375.50 M(-16.5%) |
| Sep 2017 | - | $449.81 M(-11.6%) |
| Jun 2017 | - | $508.99 M(+65.6%) |
| Mar 2017 | - | $307.38 M(-14.3%) |
| Dec 2016 | $358.59 M(+3.9%) | $358.59 M(-10.7%) |
| Sep 2016 | - | $401.45 M(+38.9%) |
| Jun 2016 | - | $289.08 M(-13.0%) |
| Mar 2016 | - | $332.37 M(-3.7%) |
| Dec 2015 | $345.12 M(-18.7%) | $345.12 M(-8.1%) |
| Sep 2015 | - | $375.66 M(-7.1%) |
| Jun 2015 | - | $404.17 M(-5.3%) |
| Mar 2015 | - | $426.82 M(+0.6%) |
| Dec 2014 | $424.37 M(+222.8%) | $424.37 M(+104.3%) |
| Sep 2014 | - | $207.75 M(+3.6%) |
| Jun 2014 | - | $200.55 M(+65.3%) |
| Mar 2014 | - | $121.34 M(-7.7%) |
| Dec 2013 | $131.48 M(+199.5%) | $131.48 M(-7.8%) |
| Sep 2013 | - | $142.59 M(+393.9%) |
| Jun 2013 | - | $28.87 M(-22.2%) |
| Mar 2013 | - | $37.12 M(-15.4%) |
| Dec 2012 | $43.90 M(-30.5%) | $43.90 M |
| Dec 2011 | $63.14 M | - |
FAQ
- What is Agios Pharmaceuticals annual stockholders equity?
- What is the all time high annual shareholders equity for Agios Pharmaceuticals?
- What is Agios Pharmaceuticals annual shareholders equity year-on-year change?
- What is Agios Pharmaceuticals quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Agios Pharmaceuticals?
- What is Agios Pharmaceuticals quarterly shareholders equity year-on-year change?
What is Agios Pharmaceuticals annual stockholders equity?
The current annual shareholders equity of AGIO is $811.02 M
What is the all time high annual shareholders equity for Agios Pharmaceuticals?
Agios Pharmaceuticals all-time high annual stockholders equity is $1.29 B
What is Agios Pharmaceuticals annual shareholders equity year-on-year change?
Over the past year, AGIO annual stockholders equity has changed by -$289.80 M (-26.33%)
What is Agios Pharmaceuticals quarterly stockholders equity?
The current quarterly shareholders equity of AGIO is $1.63 B
What is the all time high quarterly shareholders equity for Agios Pharmaceuticals?
Agios Pharmaceuticals all-time high quarterly stockholders equity is $2.30 B
What is Agios Pharmaceuticals quarterly shareholders equity year-on-year change?
Over the past year, AGIO quarterly stockholders equity has changed by +$966.16 M (+146.28%)